Tong Z, Singh G, Rainbow A J
Department of Biology, McMaster University, Hamilton, Ontario, Canada.
Photochem Photobiol. 2000 Feb;71(2):201-10. doi: 10.1562/0031-8655(2000)071<0201:trotpt>2.0.co;2.
Although there is evidence that the p53 tumor suppressor plays a role in the response of some human cells to chemotherapy and radiation therapy, its role in the response of human cells to photodynamic therapy (PDT) is less clear. In order to examine the role of p53 in cellular sensitivity to PDT, we have examined the clonogenic survival of normal human fibroblasts that express wild-type p53 and immortalized Li-Fraumeni syndrome (LFS) cells that express only mutant p53, following Photofrin-mediated PDT. The LFS cells were found to be more resistant to PDT compared to normal human fibroblasts. The D37 (LFS cells)/D37 (normal human fibroblasts) was 2.8 +/- 0.3 for seven independent experiments. Although the uptake of Photofrin per cell was 1.6 +/- 0.1-fold greater in normal human fibroblast cells compared to that in LFS cells over the range of Photofrin concentrations employed, PDT treatment at equivalent cellular Photofrin levels also demonstrated an increased resistance for LFS cells compared to normal human fibroblasts. Furthermore, adenovirus-mediated transfer and expression of wild-type p53 in LFS cells resulted in an increased sensitivity to PDT but no change in the uptake of Photofrin per cell. These results suggest a role for p53 in the response of human cells to PDT. Although normal human fibroblasts displayed increased levels of p53 following PDT, we did not detect apoptosis or any marked alteration in the cell cycle of GM38 cells, despite a marked loss of cell viability. In contrast, LFS cells exhibited a prolonged accumulation of cells in G2 phase and underwent apoptosis following PDT at equivalent Photofrin levels. The number of apoptotic LFS cells increased with time after PDT and correlated with the loss of cell viability. A p53-independent induction of apoptosis appears to be an important mechanism contributing to loss of clonogenic survival after PDT in LFS cells, whereas the induction of apoptosis does not appear to be an important mechanism leading to loss of cell survival in the more sensitive normal human fibroblasts following PDT at equivalent cellular Photofrin levels.
尽管有证据表明p53肿瘤抑制因子在一些人类细胞对化疗和放射治疗的反应中发挥作用,但其在人类细胞对光动力疗法(PDT)反应中的作用尚不清楚。为了研究p53在细胞对PDT敏感性中的作用,我们检测了表达野生型p53的正常人成纤维细胞和仅表达突变型p53的永生化李-弗劳梅尼综合征(LFS)细胞在Photofrin介导的PDT后的克隆形成存活率。结果发现,与正常人成纤维细胞相比,LFS细胞对PDT更具抗性。在七次独立实验中,D37(LFS细胞)/D37(正常人成纤维细胞)为2.8±0.3。尽管在所使用的Photofrin浓度范围内,正常人成纤维细胞中每个细胞对Photofrin的摄取量比LFS细胞高1.6±0.1倍,但在同等细胞Photofrin水平下进行PDT处理时,与正常人成纤维细胞相比,LFS细胞仍表现出更高的抗性。此外,腺病毒介导的野生型p53在LFS细胞中的转移和表达导致对PDT的敏感性增加,但每个细胞对Photofrin的摄取量没有变化。这些结果表明p53在人类细胞对PDT的反应中发挥作用。尽管正常人成纤维细胞在PDT后p53水平升高,但我们未检测到GM38细胞发生凋亡或细胞周期有任何明显改变,尽管细胞活力明显丧失。相反,在同等Photofrin水平下进行PDT后,LFS细胞在G2期出现细胞长时间积累并发生凋亡。PDT后凋亡的LFS细胞数量随时间增加,并与细胞活力丧失相关。在LFS细胞中,不依赖p53的凋亡诱导似乎是导致PDT后克隆形成存活率丧失的重要机制;而在同等细胞Photofrin水平下进行PDT后,对于更敏感的正常人成纤维细胞,凋亡诱导似乎不是导致细胞存活丧失的重要机制。